lacosamide

Generic: lacosamide

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lacosamide
Generic Name lacosamide
Labeler camber pharmaceuticals, inc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

lacosamide 10 mg/mL

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-627
Product ID 31722-627_3feb1c1a-c299-1862-e063-6394a90af07e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209301
DEA Schedule cv
Listing Expiration 2026-12-31
Marketing Start 2022-05-31

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722627
Hyphenated Format 31722-627

Supplemental Identifiers

RxCUI
993856
UPC
0331722627269 0331722627467
UNII
563KS2PQY5
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lacosamide (source: ndc)
Generic Name lacosamide (source: ndc)
Application Number ANDA209301 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (31722-627-26) / 200 mL in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (31722-627-46) / 465 mL in 1 BOTTLE
source: ndc

Packages (2)

31722-627-26 1 BOTTLE in 1 CARTON (31722-627-26) / 200 mL in 1 BOTTLE 31722-627-46 1 BOTTLE in 1 CARTON (31722-627-46) / 465 mL in 1 BOTTLE

Ingredients (1)

lacosamide (10 mg/mL)

Linked Drug Pages (1)

Lacosamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3feb1c1a-c299-1862-e063-6394a90af07e", "openfda": {"nui": ["N0000008486"], "upc": ["0331722627269", "0331722627467"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["bbd80370-3d23-41f8-8914-c6ea897c0154"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (31722-627-26)  / 200 mL in 1 BOTTLE", "package_ndc": "31722-627-26", "marketing_start_date": "20220531"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (31722-627-46)  / 465 mL in 1 BOTTLE", "package_ndc": "31722-627-46", "marketing_start_date": "20220531"}], "brand_name": "Lacosamide", "product_id": "31722-627_3feb1c1a-c299-1862-e063-6394a90af07e", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "31722-627", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA209301", "marketing_category": "ANDA", "marketing_start_date": "20220531", "listing_expiration_date": "20261231"}